CMS last week released a proposed rule that would update Medicare policies and payments for the End-Stage Renal Disease program and aims to promote the adoption of new equipment and supplies among dialysis facilities.

HHS and FDA on Wednesday unveiled two potential pathways that entities in the United States could use to safely import drugs from other countries, where they typically are sold at lower prices.

The Senate on Thursday voted 67-28 to approve a two-year budget deal that raises the U.S. debt ceiling, sets new federal spending levels, averts $125 billion in automatic spending cuts, and opens the door for negotiations on individual appropriations measures for next fiscal year.

Sen. Kamala Harris (D-Calif.), who is seeking the 2020 Democratic nomination for president, on Monday unveiled a so-called "Medicare-for-All" proposal that would allow private health insurers to offer Americans coverage modeled after Medicare Advantage plans.

Pfizer has agreed to separate and merge its off-patent drug business with Mylan in a deal that would form a new company responsible for the sales of common drugs such as EpiPen and Lipitor.

American Health Line rounds up the latest health care news in the states.

CMS on Monday issued a proposed rule to update the Medicare Physician Fee Schedule and Quality Payment Program for calendar year 2020, which includes proposals intended to reduce physicians' administrative burdens and promote value-based care.

Modern Healthcare last week released its annual Physician Compensation Survey, which lists average annual compensation for 23 provider specialties.

CMS last week rejected Utah's proposed Medicaid waiver request seeking enhanced federal funding for the state's partial Medicaid expansion, and the agency said it will not approve similar requests in the future.

A bipartisan group of House lawmakers on Thursday introduced a bill that would create a multi-agency council, as well as a $25 million federal fund, to address the social determinants of health.